Jul 9, 2020 7:23 PM
BACK TO TOP
KSE100
36,142.17
447.28
(1.25%)
ALLSHR
25,815.29
252.51
(0.99%)
KSE30
15,675.77
243.03
(1.57%)
KMI30
57,597.86
717.31
(1.26%)
BKTi
10,941.46
285.08
(2.68%)
OGTi
13,767.42
281.36
(2.09%)
KMIALLSHR
17,946.76
131.22
(0.74%)
UPP9
10,595.53
167.67
(1.61%)
NITPGI
8,130.56
130.31
(1.63%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.325.46
-5.12
(-1.55%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Jul 9, 2020 4:12 PM
REG
FUT
ODL
Open
331.20
High
333.00
Low
325.01
Volume
287,000
CIRCUIT BREAKER
305.79 — 355.37
DAY RANGE
325.01 — 333.00
52-WEEK RANGE
86.87 — 447.26
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
330.58
VAR
16.50
HAIRCUT
22.50
P/E Ratio (TTM)
25.47
1-Year Change *
185.72%
YTD Change *
55.26%
Open
330.00
High
330.00
Low
326.50
Close
326.99
Change
-1.09%
LDCP
330.58
Volume
183
Total Trades
28
CIRCUIT BREAKER
297.52 — 363.64
DAY RANGE
326.50 — 330.00
Ask Price
326.99
Ask Volume
6
Bid Price
326.07
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was subsequently converted into a public limited company. The Company is primarily engaged in the imports, manufacture and sale of pharmaceuticals products and medical devices.

KEY PEOPLE
Mrs. Akhter Khalid WaheedChairman
Mr. Osman Khalid WaheedCEO
Mr. Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
9,824,609.27
Shares
30,186,841
Free Float
12,074,736
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2020Transmission of Quarterly Report for the Period Ended 2020-03-31 View   PDF
Apr 29, 2020Financial Results for the Quarter Ended 2020-03-31 View   PDF
Feb 28, 2020Transmission of Quarterly Report for the Period Ended 2019-12-31 View   PDF
Feb 28, 2020Financial Results for the Quarter Ended 2019-12-31 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 30-09-2019 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Oct 4, 2019Transmission of Annual Report for the Year Ended 30-06-2019 View   PDF
Sep 23, 2019Financial Results for the Year Ended 2019-06-30 View   PDF
Sep 23, 2019Financial Results for the Quarter Ended 2019-06-30 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31-03-2019 View   PDF
DateTitleDocument
Jun 15, 2020Notice of Extraordinary General Meeting View   PDF
Apr 22, 2020Board Meeting View   
Feb 21, 2020Board Meeting View   
Oct 31, 2019Certified Copies of Resolutions passed in the Annual General Meeting View   PDF
Oct 18, 2019Board Meeting View   
Oct 2, 2019Notice of Annual General Meeting View   PDF
Sep 13, 2019Board Meeting View   
Apr 11, 2019Board Meeting View   
Apr 10, 2019Board Meeting View   
Feb 15, 2019Board Meeting View   
DateTitleDocument
Jul 6, 2020Election of Directors View   PDF
Jul 1, 2020Election of Directors View   PDF
Jun 29, 2020Election of Directors View   PDF
Jun 16, 2020Notice under section 159(4) of the Companies Act, 2017 View   PDF
May 13, 2020Material Information View   PDF
May 11, 2020Material Information View   PDF
Mar 4, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 17, 2020Material Information View   
Nov 18, 2019Corporate Briefing Session (CBS) View   PDF
Nov 13, 2019Credit of Final Cash Dividend View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales5,180,8044,459,3234,311,44210,186,496
Profit after Taxation251,04695,406393,6652,104,486
EPS8.323.1613.0469.72
Q3 2020Q2 2020Q1 2020Q3 2019
Sales1,570,0701,334,3271,188,8281,242,028
Profit after Taxation110,98695,12683,00213,132
EPS3.683.152.750.43
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)39.4935.2041.2140.34
Net Profit Margin (%)4.852.149.1320.66
EPS Growth (%)163.29(75.77)(81.30)181.13
PEG0.08(0.81)(0.36)0.08

Payouts

DateFinancial ResultsDetailsBook Closure
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016
January 26, 2016 9:54 AM31/12/2015(HYR) 100%(I) (D) 20/02/2016 - 26/02/2016
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
February 16, 2015 3:52 PM31/12/2015(HYR) 40%(I) (D) 13/03/2015 - 20/03/2015

Financial Reports